These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1411 related items for PubMed ID: 28096098

  • 1. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
    Duncker D, König T, Hohmann S, Bauersachs J, Veltmann C.
    J Am Heart Assoc; 2017 Jan 17; 6(1):. PubMed ID: 28096098
    [Abstract] [Full Text] [Related]

  • 2. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
    Röger S, Rosenkaimer SL, Hohneck A, Lang S, El-Battrawy I, Rudic B, Tülümen E, Stach K, Kuschyk J, Akin I, Borggrefe M.
    BMC Cardiovasc Disord; 2018 Mar 15; 18(1):52. PubMed ID: 29544442
    [Abstract] [Full Text] [Related]

  • 3. Ventricular arrhythmias in patients with newly diagnosed nonischemic cardiomyopathy: Insights from the PROLONG study.
    Duncker D, König T, Hohmann S, Bauersachs J, Veltmann C.
    Clin Cardiol; 2017 Aug 15; 40(8):586-590. PubMed ID: 28333373
    [Abstract] [Full Text] [Related]

  • 4. Avoiding implantation of a cardioverter-defibrillator by bridging with wearable defibrillator vest.
    Klein N, Kuntz T, Dhein S.
    Herz; 2021 Mar 15; 46(2):172-177. PubMed ID: 31555894
    [Abstract] [Full Text] [Related]

  • 5. The wearable cardioverter-defibrillator in a real-world clinical setting: experience in 102 consecutive patients.
    Erath JW, Vamos M, Sirat AS, Hohnloser SH.
    Clin Res Cardiol; 2017 Apr 15; 106(4):300-306. PubMed ID: 27888304
    [Abstract] [Full Text] [Related]

  • 6. Delayed Improvement of Left Ventricular Function in Newly Diagnosed Heart Failure Depends on Etiology-A PROLONG-II Substudy.
    Mueller-Leisse J, Brunn J, Zormpas C, Hohmann S, Hillmann HAK, Eiringhaus J, Bauersachs J, Veltmann C, Duncker D.
    Sensors (Basel); 2022 Mar 05; 22(5):. PubMed ID: 35271182
    [Abstract] [Full Text] [Related]

  • 7. The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital.
    Sinha AM, Bense J, Hohenforst-Schmidt W.
    J Interv Card Electrophysiol; 2021 Nov 05; 62(2):401-407. PubMed ID: 33200285
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the Outcome of Patients Protected by the Wearable Cardioverter Defibrillator (WCD) for <90 Wear Days versus ≥90 Wear Days.
    Dreher TC, El-Battrawy I, RÖger S, Rosenkaimer SL, Gerhards S, Kuschyk J, Borggrefe M, Akin I.
    In Vivo; 2020 Nov 05; 34(6):3601-3610. PubMed ID: 33144474
    [Abstract] [Full Text] [Related]

  • 9. Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: A national database analysis.
    Opreanu M, Wan C, Singh V, Salehi N, Ahmad J, Szymkiewicz SJ, Thakur RK.
    J Heart Lung Transplant; 2015 Oct 05; 34(10):1305-9. PubMed ID: 26094085
    [Abstract] [Full Text] [Related]

  • 10. Study of the wearable cardioverter defibrillator in advanced heart-failure patients (SWIFT).
    Barsheshet A, Kutyifa V, Vamvouris T, Moss AJ, Biton Y, Chen L, Storozynsky E, Wan C, Szymkiewicz SJ, Goldenberg I.
    J Cardiovasc Electrophysiol; 2017 Jul 05; 28(7):778-784. PubMed ID: 28429542
    [Abstract] [Full Text] [Related]

  • 11. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU, Goldenberg I, Moss AJ.
    Eur Heart J; 2013 Aug 05; 34(29):2230-42. PubMed ID: 23729691
    [Abstract] [Full Text] [Related]

  • 12. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V, Moss AJ, Klein H, Biton Y, McNitt S, MacKecknie B, Zareba W, Goldenberg I.
    Circulation; 2015 Oct 27; 132(17):1613-9. PubMed ID: 26316618
    [Abstract] [Full Text] [Related]

  • 13. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.
    Epstein AE, Abraham WT, Bianco NR, Kern KB, Mirro M, Rao SV, Rhee EK, Solomon SD, Szymkiewicz SJ.
    J Am Coll Cardiol; 2013 Nov 19; 62(21):2000-2007. PubMed ID: 23916930
    [Abstract] [Full Text] [Related]

  • 14. Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator.
    Duncker D, Haghikia A, König T, Hohmann S, Gutleben KJ, Westenfeld R, Oswald H, Klein H, Bauersachs J, Hilfiker-Kleiner D, Veltmann C.
    Eur J Heart Fail; 2014 Dec 19; 16(12):1331-6. PubMed ID: 25371320
    [Abstract] [Full Text] [Related]

  • 15. Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry.
    Veltmann C, Winter S, Duncker D, Jungbauer CG, Wäßnig NK, Geller JC, Erath JW, Goeing O, Perings C, Ulbrich M, Roser M, Husser D, Gansera LS, Soezener K, Malur FM, Block M, Fetsch T, Kutyifa V, Klein HU.
    Clin Res Cardiol; 2021 Jan 19; 110(1):102-113. PubMed ID: 32377784
    [Abstract] [Full Text] [Related]

  • 16. Wearable cardioverter defibrillator multicentre experience in a large cardiac surgery cohort at transient risk of sudden cardiac death.
    Kuehn C, Ruemke S, Rellecke P, Lichtenberg A, Joskowiak D, Hagl C, Hassan M, Leyh RG, Erler S, Garbade J, Eifert S, Grieshaber P, Boening A, Doenst T, Velichkov I, Madej T, Knaut M, Hain A, Burger H.
    Eur J Cardiothorac Surg; 2022 May 02; 61(5):1031-1040. PubMed ID: 35174386
    [Abstract] [Full Text] [Related]

  • 17. Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland.
    Kovacs B, Reek S, Saguner AM, Krasniqi N, Eriksson U, Duru F.
    Swiss Med Wkly; 2019 Nov 04; 149():w20136. PubMed ID: 31707723
    [Abstract] [Full Text] [Related]

  • 18. Effective treatment of electrical storm by a wearable cardioverter defibrillator in a patient with severely impaired left ventricular function after myocardial infarction: a case report.
    Andresen H, Sasko B, Patschan D, Pagonas N, Ritter O.
    J Med Case Rep; 2021 May 17; 15(1):243. PubMed ID: 33993888
    [Abstract] [Full Text] [Related]

  • 19. Wearable cardioverter defibrillator after cardiac surgery: Analysis of real-life data from patients at transient risk of sudden cardiac death.
    Elbayomi M, Weyand M, Seitz T, Harig F.
    Ann Noninvasive Electrocardiol; 2023 Mar 17; 28(2):e13048. PubMed ID: 36723848
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 71.